CLINICAL TRIALS PROFILE FOR ELREXFIO
✉ Email this page to a colleague
All Clinical Trials for ELREXFIO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT06057402 ↗ | Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) | Recruiting | Pfizer | Phase 4 | 2023-10-03 | This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ELREXFIO
Condition Name
Clinical Trial Locations for ELREXFIO
Trials by Country
Clinical Trial Progress for ELREXFIO
Clinical Trial Phase
Clinical Trial Sponsors for ELREXFIO
Sponsor Name